MRI contrast agents and high-throughput screening by MRI
US8568690B2 · kind B2 · utility
5Cited by
46References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2008 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | Mar 12, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an MRI contrast agent, comprising: MRI contrast agent particles, and oligonucleotides, attached to the particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.